| 000 | 01115 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517213231.0 | ||
| 264 | 0 | _c20190415 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a0929-6646 | ||
| 024 | 7 |
_a10.1016/j.jfma.2018.04.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Chih-Lin | |
| 245 | 0 | 0 |
_aCombination therapy for chronic hepatitis B: The future and beyond. _h[electronic resource] |
| 260 |
_bJournal of the Formosan Medical Association = Taiwan yi zhi _c08 2018 |
||
| 300 |
_a745-746 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHepatitis B e Antigens |
| 650 | 0 | 4 | _aHepatitis B, Chronic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon-alpha |
| 650 | 0 | 4 | _aOrganophosphonates |
| 650 | 0 | 4 | _aPolyethylene Glycols |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 773 | 0 |
_tJournal of the Formosan Medical Association = Taiwan yi zhi _gvol. 117 _gno. 8 _gp. 745-746 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jfma.2018.04.006 _zAvailable from publisher's website |
| 999 |
_c28336250 _d28336250 |
||